Old Web
English
Sign In
Acemap
>
Paper
>
The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection
The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection
2019
Joann D. Kuruc
Shane D. Falcinelli
Joanna A. Warren
J. Kirchherr
K. Sholtis
Brigitte Allard
Erin Stuelke
Alicia H. Gamble
Ana Plachco
I. Tcherapanova
Joseph J. Eron
Nilu Goonetilleke
Mark DeBenedette
Charles A. Nicolette
Nancie M. Archin
David Margolis
Keywords:
Dendritic cell
human immunodeficiency virus
Cancer research
Immunotherapy
Medicine
Vorinostat
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]